Showing results (101-110 of 273) with videos related to

Sort By:
Pageof 28
Proceedings of the National Academy of Sciences of the United States of America|November 25, 1998
Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivoK Maruno, A Absood, S I Said
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1975
Vasoactive intestinal polypoptide: inactivation in liver and potentiation in lung of anesthetized dogs (384699)S Kitamura, T Yoshida, S I Said
European Journal of Pharmacology|October 17, 1980
Effect of VIP, phenoxybenzamine and prednisolone on cyclic nucleotide content of isolated guinea-pig lung and tracheaS Kitamura, Y Ishihara, S I Said
European Journal of Biochemistry|September 22, 1999
Isolation and characterization of sulphated and nonsulphated forms of cholecystokinin-58 and their action on gallbladder contractionV Bonetto, H Jörnvall, M Andersson, et al.
Acta Physiologica Scandinavica|April 1, 1991
Dual effects of vasoactive intestinal peptide (VIP) on leucocyte migrationL Bondesson, K Norolind, S Lidén, et al.
Acta Chemica Scandinavica (Copenhagen, Denmark : 1989)|January 1, 1991
A fragment of triosephosphate isomerase competes with the vasoactive intestinal polypeptide (VIP) for binding to the VIP receptorG Gafvelin, T Bergman, M Andersson, et al.
Pageof 28